Screen-detected diabetes, hypertension and hypercholesterolemia as predictors of cardiovascular mortality in five populations of Asian origin: the DECODA study

被引:100
作者
Nakagami, Tomoko
Qiao, Qing
Tuomilehto, Jaakko
Tajima, Naoko
Hu, Gang
Borch-Johnsen, Knut
机构
[1] Tokyo Womens Med Univ, Ctr Diabet, Shinjuku Ku, Tokyo 1628666, Japan
[2] Natl Publ Hlth Inst, Dept Epidemiol & Hlth Promot, Helsinki, Finland
[3] Univ Helsinki, Dept Publ Hlth, Helsinki, Finland
[4] INSERM, U258, Villejuif, France
[5] Jikei Univ, Sch Med, Dept Internal Med, Div Diabet & Endocrinol, Tokyo, Japan
[6] Steno Diabet Ctr, DK-2820 Gentofte, Denmark
来源
EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION | 2006年 / 13卷 / 04期
基金
芬兰科学院;
关键词
Asia; cardiovascular disease; hypercholesteremia; hypertension; screen-detected diabetes; screening;
D O I
10.1097/01.hjr.0000183916.28354.69
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Background The World Health Organization (WHO) predicts that the Asia Pacific region will experience an increase in cardiovascular disease (CVD) as a result of demographic changes and an increasing prevalence of diabetes. The aims of this study were to assess the predictive value of glucose tolerance status as a risk factor for CVD and identify a high-risk group for fatal CVD in population-based studies of Asians. Design A meta-analysis of five prospective cohort studies of Japanese and Asian Indian origin from five countries. Methods A total of 6573 subjects without a history of CVD from five prospective studies were followed for 5-10 years. Diabetes at baseline was diagnosed according to 1999 WHO criteria. Hazard ratios for death from CVD were estimated using a Cox proportional hazard model, adjusting for glucose tolerance status together with established risk factors for CVD. Results The meta-analysis showed that the overall hazard ratios (95% confidence interval) for CVD mortality corresponding to the presence of screen-detected diabetes, hypertension and hypercholesteremia were 3.42 (2.23-5.23), 1.57 (1.10-2.24) and 1.49 (1.05-2.10), respectively. Stratified multivariate analysis of the pooled data showed that subjects with screen-detected diabetes in the presence of hypertension or hypercholesteremia had the highest risk of CVD in individuals without previous CVD or diabetes. Subjects with screen-detected diabetes in the presence of hypertension or hypercholesteremia comprised 78% of CVD deaths that occurred in all subjects with screen-detected diabetes. Conclusions The early detection of undiagnosed diabetes in hypertension or hypercholesteremia may have clinical and public health implications for the primary prevention of rapidly increasing diabetes-related atherosclerotic CVD in Asian populations.
引用
收藏
页码:555 / 561
页数:7
相关论文
共 37 条
[1]
Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO
[2]
2-S
[3]
[Anonymous], 1997, INT CLASSIFICATION D
[4]
Chalmers J, 1999, J HYPERTENS, V17, P151
[5]
Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].
Cleeman, JI ;
Grundy, SM ;
Becker, D ;
Clark, LT ;
Cooper, RS ;
Denke, MA ;
Howard, WJ ;
Hunninghake, DB ;
Illingworth, DR ;
Luepker, RV ;
McBride, P ;
McKenney, JM ;
Pasternak, RC ;
Stone, NJ ;
Van Horn, L ;
Brewer, HB ;
Ernst, ND ;
Gordon, D ;
Levy, D ;
Rifkind, B ;
Rossouw, JE ;
Savage, P ;
Haffner, SM ;
Orloff, DG ;
Proschan, MA ;
Schwartz, JS ;
Sempos, CT ;
Shero, ST ;
Murray, EZ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497
[6]
Estimation of ten-year risk of fatal cardiovascular disease in Europe:: the SCORE project [J].
Conroy, RM ;
Pyörälä, K ;
Fitzgerald, AP ;
Sans, S ;
Menotti, A ;
De Backer, G ;
De Bacquer, D ;
Ducimetière, P ;
Jousilahti, P ;
Keil, U ;
Njolstad, I ;
Oganov, RG ;
Thomsen, T ;
Tunstall-Pedoe, H ;
Tverdal, A ;
Wedel, H ;
Whincup, P ;
Wilhelmsen, L ;
Graham, IM .
EUROPEAN HEART JOURNAL, 2003, 24 (11) :987-1003
[7]
Decreased serum levels of adiponectin are a risk factor for the progression to type 2 diabetes in the Japanese population - The Funagata study [J].
Daimon, M ;
Oizumi, T ;
Saitoh, T ;
Kameda, W ;
Hirata, A ;
Yamaguchi, H ;
Ohnuma, H ;
Igarashi, M ;
Tominaga, M ;
Kato, T .
DIABETES CARE, 2003, 26 (07) :2015-2020
[8]
European guidelines on cardiovascular disease prevention in clinical practice -: Third Joint Task Force of European and other Societies on Cardiovascular Disease Prevention in Clinical Practice [J].
De Backer, G ;
Ambrosioni, E ;
Borch-Johnsen, K ;
Brotons, C ;
Cifkova, R ;
Dallongeville, J ;
Ebrahim, S ;
Faergeman, O ;
Graham, I ;
Mancia, G ;
Cats, VM ;
Orth-Gomér, K ;
Perk, J ;
Pyörälä, K ;
Rodicio, JL ;
Sans, S ;
Sansoy, V ;
Sechtem, U ;
Silber, S ;
Thomsen, T ;
Wood, D .
EUROPEAN HEART JOURNAL, 2003, 24 (17) :1601-1610
[9]
CHANGES IN POPULATION CHOLESTEROL CONCENTRATIONS AND OTHER CARDIOVASCULAR RISK FACTOR LEVELS AFTER 5 YEARS OF THE NONCOMMUNICABLE DISEASE INTERVENTION PROGRAM IN MAURITIUS [J].
DOWSE, GK ;
GAREEBOO, H ;
ALBERTI, KGMM ;
ZIMMET, P ;
TUOMILEHTO, J ;
PURRAN, A ;
FAREED, D ;
CHITSON, P ;
COLLINS, VR ;
HEMRAJ, F .
BRITISH MEDICAL JOURNAL, 1995, 311 (7015) :1255-1259
[10]
Fleiss J L, 1993, Stat Methods Med Res, V2, P121, DOI 10.1177/096228029300200202